4-Diazopyrazole derivatives as potential new antibiofilm agents

Chemotherapy

Volumn 54, Issue 6, 2008, Pages 456-462

  Schillaci, Domenico ^a   Maggio, Benedetta ^a   Raffa, Demetrio ^a   Daidone, Giuseppe ^a   Cascioferro, Stella ^a   Cusimano, Maria Grazia ^a   Raimondi, Maria Valeria ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Antibiofilm activity; Candida albicans biofilms; Diazopyrazoles; Staphylococcal biofilms

Indexed keywords

4 DIAZOPYRAZOLE DERIVATIVE; ANTIINFECTIVE AGENT; PYRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BIOFILM; CANDIDA ALBICANS; CONTROLLED STUDY; DEVICE INFECTION; DRUG SENSITIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

AZA COMPOUNDS; BIOFILMS; CANDIDA ALBICANS; MOLECULAR STRUCTURE; PYRAZOLES; STAPHYLOCOCCUS;

EID: 52849135125     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000159271     Document Type: Article

References (17)

1. Post JC, Hiller NL, Nistico L, Stoodley P, Ehrlich GD: The role of biofilms in otolaryngologic infections: update 2007. Curr Opin Otolaryngol Head Neck Surg 2007;15:347-351.
2. Götz F: Staphylococcus and biofilms. Mol Microbiol 2002;43:1367-1378.
3. Donelli G, Francolini I, Romoli D, Guaglianone E, Piozzi A, Ragunath C, Kaplan JB: Synergistic activity of dispersin B and cefamandole nafate in inhibition of staphylococcal biofilm growth on polyurethanes. Antimicrob Agents Chemother 2006;51:2733-2740.
4. Wesenberg-Ward KE, Tyler BJ, Sears JT: Adhesion and biofilm formation of Candida albicans on native and Pluronic-treated polystyrene. Biofilms 2005;2:63-71.
5. Douglas LJ: Candida and their role in infection. Trends Microbiol 2003;11:30-36.
6. Projan SJ, Youngman PJ: Antimicrobials: new solutions badly needed. Curr Opin Microbiol 2002;5:463-465.
7. Cirrincione G, Almerico AM, Aiello E, Dattolo G: Advances in heterocyclic chemistry; in Katzitzky AR (ed): Diazoazoles. New York, Academic Press, 1990, vol 48, pp 161-163 and references cited therein.
8. Daidone G, Bajardi ML, Plescia S, Raffa D, Schillaci D, Maggio B; Bentollo F, Bombieri G: One-step synthesis, crystallographic studies and antimicrobial activity of new 4-diazopyrazole derivatives. Eur J Med Chem 1996;31:461-468.
9. Alem MAS, Douglas LJ: Effects of aspirin and other non-steroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans. Antimicrob Agents Chemother 2004;48:41-47.
10. National Committee for Clinical Laboratory Standards (NCCLS): Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard, ed 3. NCCLS document M7-A3. Villanova, NCCLS, 1993, vol 13.
11. Peck KR, Kim SW, Jung SI, Kim YS, Oh WS, Lee JY, Jin JH, Kim S, Song JH, Kobayashi H: Antimicrobials as potential adjunctive agents in the treatment of biofilm infection with Staphylococcus epidermidis. Chemotherapy 2003;49:189-93.
12. Saginur R, Stdenis M, Ferris W, Aaron SD, Chan F, Lee C, Ramotar K: Multiple combination bactericidal testing of staphylococcus biofilms from implant-associated infections. Antimicrob Agents Chemother 2006;50:55-61.
13. Mah TC, O'Toole G.A: Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001;9:34-39.
14. Mitchell AP: Dimorphism and virulence in Candida albicans. Curr Opin Microbiol 1998;1:687-692.
15. Blankenship JR, Mitchell AP: How to build a biofilm: a fungal perspective. Curr Opin Microbiol 2006;9:588-594.
16. Chandra J, Zhou G, Ghannoum MA: Fungal biofilms and antimycotics. Curr Drug Targets 2005;6:287-294.
17. Akiyama H, Oono T, Huh W-K, Yamasaki O, Ogawa S, Katsuyama M, Ichikawa H, Iwatsuki K: Actions of farnesol and xylitol against Staphylococcus aureus. Chemotherapy 2002;48:122-128.